Advanced Paraganglioma
1 clinical trials · Condition
◉ Watch Advanced Paraganglioma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer (NCT04394858) | National Cancer Institute (NCI) | 2021-03-17 |
Track Advanced Paraganglioma automatically
Every clearance here is in the API, with alerts when new ones post.